Article

Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents.

Klinik für Pädiatrische Pneumologie und Allergologie, Neonatologie und Intensivmedizin, Elisabeth-Kinderkrankenhaus, Oldenburg, Germany.
Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología (Impact Factor: 2.64). 02/2009; 19(2):125-31.
Source: PubMed

ABSTRACT We conducted a large observational study in 193 children and adolescents with allergic rhinitis due to grass or tree pollens to evaluate the safety and tolerability of an ultrarush high-dose sublingual immunotherapy (SLIT) regimen reaching a maintenance dose of 300 index of reactivity within 90 minutes.
Children and adolescents aged 5 to 17 years with at least a 1-year medical history of allergic rhinitis with or without mild to moderate asthma due to tree pollens (birch, alder, hazel) or grass pollens (cocksfoot, meadow grass, rye grass, sweet vernal grass, timothy) were recruited. Standardized grass and tree pollen allergen extracts were used for ultrarush titration and subsequent coseasonal maintenance.
During ultrarush titration, 60 patients (31%) reported 117 predominantly mild and local adverse events, which resolved within 150 minutes. During the maintenance phase, 562 adverse events were reported; the most frequent local events were oral pruritus, burning sensation, lip or tongue swelling, and gastrointestinal symptoms, and the most frequent systemic events were rhinoconjunctivitis and asthma. There was 1 clinically significant asthma event in an 11-year old boy with known asthma in whom SLIT was resumed after an interval of 4 days.
Ultrarush titration was safe and well tolerated. Pediatric patients with asthma should be carefully monitored and adequately trained to use their rescue medications.

0 Followers
 · 
62 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As during previous years, numerous studies have been published aiming to increase knowledge of pathophysiology, epidemiology, (early) diagnosis, prevention and treatment of respiratory allergy and asthma in children. Most important findings concern the role of new viruses (typeC rhinoviruses especially) as a cause of infant bronchiolitis, and the long-lasting bronchial inflammation induced by respiratory virus infections, which may promote subsequent asthma development. Interactions between genetic and environmental (allergenic and non allergenic) factors are highlighted in several important studies, as well as statistically significant relationships between asthma and overweight/obesity. Inhaled corticosteroids associated with long-acting bronchodilators are more efficient than inhaled corticosteroids alone. Finally, several studies including numerous children show that sublingual immunotherapy is efficient in pollen and/or mite-allergic rhinitis and/or asthma in children. However, the length of efficacy of sublingual immunotherapy may be shorter than reported for subcutaneous immunotherapy.
    Revue Française d Allergologie 12/2010; 50(8):637-652. DOI:10.1016/j.reval.2010.09.006 · 0.22 Impact Factor
  • Source
    World Allergy Organization Journal 01/2007; DOI:10.1097/01.WOX.0000301986.60236.8c
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Conventional immunotherapy for allergy with 3-5 years of treatment period has poor compliance. Ultra-rush sublingual immunotherapy with a shorter period of treatment can have better compliance. There are very few studies on ultra-rush sublingual immunotherapy all over the world. OBJECTIVES: (1) To determine allergen sensitivity among allergic rhinitis patients. (2) To assess safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy. METHODS: The present study was conducted in Allergy clinic, KIMS Hospital & Research Centre, Bangalore, India from January 2010 to June 2011. After obtaining Institutional Ethics Committee approval, 40 allergic rhinitis patients (according to ARIA guidelines) in the 18-60 years age group who were positive for aeroallergens in skin prick test were recruited for ultra-rush sublingual immunotherapy (20min initial phase and 4-month maintenance phase) and followed for 8 months with symptom and treatment diary. RESULTS: Out of 40 patients, the majority, 36 (90.00%) patients were sensitive to house dust mites. Six patients had seven immediate adverse reactions and seven patients had eight delayed adverse reactions. All subsided without medication or with symptomatic oral medications. All patients tolerated ultra-rush SLIT and there was significant decrease in both symptom-score and treatment received in these patients. CONCLUSION: Ultra-rush SLIT regimen has excellent safety, tolerability and clinical efficacy among allergic rhinitis patients.
    Allergologia et Immunopathologia 03/2013; 42(3). DOI:10.1016/j.aller.2012.12.005 · 1.58 Impact Factor

Preview

Download
0 Downloads
Available from